Science Mag reported that this was about two weeks ago, we reported on this as

well that science mag wrote that WHO's solidarity trial for Remdesivir. This is

the anti-viral that was repurposed for COVID-19 false flat. So they released

their their data and this is the biggest study in the world and it showed that it

basically had little little effect and so the FDA approved this drug and did they

look at the WHO study, the biggest study in the world. Don't take it for me, take

it from Chief Scientist at WHO's is Dr. Swamin Yatin. Take a look at this.

Okay. What we understand from the FDA decision yesterday was based on data

submitted to them from Gilead which did not include the solidarity trial

results. We have submitted the solidarity trial results to Gilead. They first

saw the results on the 23rd of September and then saw the full manuscript on

the 28th of September. So they did have the results even before they were made

public through Medarkiv because we give them give it to them 10 days in advance.

So it appears that the solidarity results were not considered, were not

provided to the FDA. We believe that this it is the largest trial in the world,

globally, 5000 patients were randomized to either endesphere or standard of care.

We looked at very important endpoints in hospital mortality, no difference.

92% of people who entered this trial were randomized to this trial were not on

mechanical ventilation. So we looked at how many of those progressed to need

ventilation, exactly similar numbers in the remdesivir and the control arm.

It's outrageous. I remember when we were reporting on this just a couple of weeks ago

and it's, I mean this huge study shows this remdesivir does not really

...